Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development

被引:35
作者
Locher, CP
Witt, SA
Herndier, BG
Tenner-Racz, K
Racz, P
Levy, JA
机构
[1] Univ Calif San Francisco, Dept Pathol, San Francisco Gen Hosp, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, Div Hematol & Oncol, San Francisco Gen Hosp, San Francisco, CA 94143 USA
[3] Bernhard Nocht Inst Trop Med, Hamburg, Germany
关键词
D O I
10.1034/j.1600-065x.2001.1830111.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Baboons (Papio cynocephalus) provide a valuable animal model for the study of human immunodeficiency virus (HIV) pathogenesis because HIV-2 infection of baboons causes a chronic viral disease that progresses over several years before clinical signs of acquired immunodeficiency syndrome (AIDS) appear. Since HIV-2-infected baboons develop a chronic viral infection, insights into the immuno-biology of viral latency, clinical stages of disease, virus infection of lymphatic tissue and HI-V transmission can be gained using this animal model. The development of an AIDS-like disease in baboons is viral isolate and baboon subspecies dependent. Thus, viral virulence factors and host resistance can be studied as well as the mechanisms of innate and acquired immunity. The control of virus infection is dependent upon cytotoxic and non-cytotoxic antiviral activity of CD8(+) T cells. In this regard, some of the HIV-2-infected baboons develop potent antiviral cellular immune responses that have a similar magnitude to that found in HIV-1-infected long-term survivors (or non-progressors). In our laboratory, baboons have been used to study DNA vaccine strategies using new cationic liposome formulations and granulocyte macrophage-colony stimulating factor and B7-2 as genetic adjuvants. The results demonstrate the value of using baboons as an animal model of AEDS pathogenesis and vaccine development.
引用
收藏
页码:127 / 140
页数:14
相关论文
共 103 条
[1]   INFECTION OF MACACA-NEMESTRINA BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
AGY, MB ;
FRUMKIN, LR ;
COREY, L ;
COOMBS, RW ;
WOLINSKY, SM ;
KOEHLER, J ;
MORTON, WR ;
KATZE, MG .
SCIENCE, 1992, 257 (5066) :103-106
[2]   Immunoreactive cytokines within primates [J].
Ahne, W ;
Mayr, A ;
Wiesner, H .
JOURNAL OF VETERINARY MEDICINE SERIES B-INFECTIOUS DISEASES AND VETERINARY PUBLIC HEALTH, 1996, 43 (10) :607-611
[3]  
ALLAN JS, 1995, J ACQ IMMUN DEF SYND, V9, P429
[4]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[5]  
An LL, 1999, CURR OPIN MOL THER, V1, P16
[6]  
Apostolopoulos V, 2000, CURR OPIN MOL THER, V2, P441
[7]   The role of CD80 and CD86 in enhancing CD8+ cell suppression of HIV replication [J].
Barker, E ;
Bossart, KN ;
Fujimura, SH ;
Levy, JA .
CELLULAR IMMUNOLOGY, 1999, 196 (02) :95-103
[8]   Molecular cloning of the human immunodeficiency virus subtype 2 strain HIV-2(UC2) [J].
Barnett, SW ;
Legg, HS ;
Sun, Y ;
Klinger, J ;
Blackbourn, DJ ;
Locher, CP ;
Levy, JA .
VIROLOGY, 1996, 222 (01) :257-261
[9]   AN AIDS-LIKE CONDITION INDUCED IN BABOONS BY HIV-2 [J].
BARNETT, SW ;
MURTHY, KK ;
HERNDIER, BG ;
LEVY, JA .
SCIENCE, 1994, 266 (5185) :642-646
[10]   Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].
Barouch, DH ;
Santra, S ;
Schmitz, JE ;
Kuroda, MJ ;
Fu, TM ;
Wagner, W ;
Bilska, M ;
Craiu, A ;
Zheng, XX ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Nickerson, CE ;
Trigona, WL ;
Punt, K ;
Freed, DC ;
Guan, LM ;
Dubey, S ;
Casimiro, D ;
Simon, A ;
Davies, ME ;
Chastain, M ;
Strom, TB ;
Gelman, RS ;
Montefiori, DC ;
Lewis, MG ;
Emini, EA ;
Shiver, JW ;
Letvin, NL .
SCIENCE, 2000, 290 (5491) :486-492